Islatravir Safe, Tolerable for HIV-1 PrEP in Phase 2A Trial

islatravir safe tolerable for hiv 1 prep in phase 2a trial

Sumary of Islatravir Safe, Tolerable for HIV-1 PrEP in Phase 2A Trial:

  • New phase 2A trial data suggest once-monthly pre-exposure prophylaxis (PrEP) islatravir, an investigational nucleoside reverse transcriptase translocation inhibitor, was generally well tolerated and associated with mostly mild adverse events versus placebo in patients at low risk of contracting HIV-1 infection.

Want to know more click here go to source.

From -

Close
Generic selectors
Exact matches only
Search in title
Search in content

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close